| |
|
|
|
Capricor Therapeutics Inc.  
|
|
4.38 -0.18 (-0.04%) |
07-10 16:00 |
|
Open: |
4.54 |
Pre close: |
4.56 |
Target:
|
6.08
|
|
High: |
4.54 |
Low: |
4.32 |
Resistance:
|
5.21
5.85
|
|
Volume: |
489,476 |
Market Cap: |
55M |
Support:
|
4.17
3.47
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.50
 |
MACD |
MACD(12,26):
|
-0.10 |
|
MA(20): |
4.74  |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
3.43 |
Stochastic Oscillator |
%K(14,3):
|
18.66 |
|
MA(250): |
2.84 |
%D(3): |
19.29 |
|
Average Volume(K) |
3-Month: |
582179
|
52-Week |
High:
|
11.08 |
|
10-Days: |
59960 |
Low: |
0.88 |
|
RSI |
RSI(14):
|
43.11 |
Change(%): |
-29.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.570 |
Return on Equity (ttm) |
-108.1 |
Shares Out. (M) |
12.46 |
|
EPS Est. Current Year |
-0.700 |
Return on Assets (ttm) |
-39.7 |
Shares Float (M) |
13.78 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.21 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
-19.4 |
% Held by Institutions |
3.69 |
|
Forward EPS |
-2.060 |
Gross Profit (p.s.) |
-0.332 |
Shares Short (K) |
274 |
|
Book Value (p.s.) |
1.040 |
EBITDA (p.s.) |
-0.571 |
P/E |
-2.79 |
|
Sales Per Share |
0.077 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.21 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.43 |
P/S |
56.83 |
|
Operating Margin |
-758.60 |
Levered Free Cash Flow
(M) |
-3.62 |
P/CF |
-8.49 |
|
|
|
|
|
|
